Improved Adherence To Diabetes Drugs Can Lower Hospitalizations 13%, Study Finds
This article was originally published in The Pink Sheet Daily
Executive Summary
Researchers at Harvard and Express Scripts estimate that improved adherence to diabetes drugs could save nearly $5 billion annually across the U.S. health care system.
You may also be interested in...
Express Scripts Launches “Virtual Coaching” To Help With Medication Adherence
The online service is aimed at helping patients understand their disease states and properly administering self-injected drugs. Pharmaceutical manufacturers could help develop content.
Making The Business Of Drug Adherence An Easier Pill To Swallow
Medication adherence is a big problem, and recent studies are bringing the actual costs and causes into sharper focus. At the same time, health care reforms such as electronic health records and prescriptions, as well as new incentives from the US government, have encouraged investors to tackle solutions to the problem. Questions remain about the impact of these reforms, but the companies profiled in this issue, HealthPrize Technologies, PillJogger, RxAnte and SentiCare, see an evolving climate in which their medication adherence technology solutions can turn into profitable businesses.
HealthPrize Technologies LLC
HealthPrize Technologies LLC, a company developing Internet and mobile-based gaming and loyalty rewards applications, hopes to teach the industry how to motivate reluctant patients to take their medicine. By making behavioral psychology part of the prescription, the start-up thinks that pharmaceutical companies, payors and providers will reward it for boosting adherence rates.